IP Library Patent Application 17634671
Patent Application
App. No. 17/634,671

Drinkable Supplement Composition for Improved Health and Hydration

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/634,671
Filed
Feb 11, 2022
Art Unit
1645
USPC
424/93.45
Abstract

The present invention provides compositions and methods for enhancing the health of a subject by, for example, restoring the subjects gut microbiome, increasing water and electrolyte absorption in the digestive tract, and/or providing a therapeutic substance to the subject. In certain specific embodiments, the present invention can be used for ameliorating the adverse physiological effects that can result from the presence of one or more detrimental microorganisms in a subjects gut. In certain specific embodiments, the present invention can also be used as an enhanced mode of hydration or re-hydration, particularly for subjects suffering from, for example, a condition that causes vomiting and/or diarrhea.

Claims (30)

1 . A method for enhancing a subject's health, the method comprising administering to the subject a composition comprising water, a biosurfactant,

electrolytes,

a beneficial microorganism, and an additive

selected from nutrients, vitamins, minerals, herbal extracts, proteins, amino acids, antioxidants, and health supplements,

wherein the method results in an increase in water and/or electrolyte absorption in the subject's digestive tract, restoration of the subject's gut microbiome, and/or providing a therapeutic substance to the subject.

2 . (canceled)

3 . The method of claim 1 , comprising a biosurfactant selected from glycolipids, lipopeptides and/or phospholipids.

4 . The method of claim 1 , wherein the composition is administered to the subject via ingestion.

5 . The method of claim 1 , comprising electrolytes selected from sodium, potassium, phosphate, bicarbonate, sulfate, chloride, calcium and/or magnesium.

6 . The method of claim 1 , comprising a beneficial microorganism selected from Bacillus spp., Bacteroides spp., Bifidobacterium spp., and Lactobacillus spp.

7 . The method of claim 6 , wherein the microorganism is selected from Bacillus subtilis natto, Bacillus amyloliquefaciens or Bacillus coagulans.

8 . The method of claim 1 , comprising one or more additives selected from nattokinase, CoQ10 and cannabidiol.

9 . (canceled)

10 . The method of claim 1 , wherein the subject's gut microbiome has been disrupted or unbalanced as a result of antibiotic treatment, illness, infection, dietary factors, radiation treatment or exposure, colonoscopy, appendectomy, and/or aging.

11 . The method of claim 1 , wherein the subject is dehydrated due to physical exertion, heat exhaustion, drug side-effects, or a condition that causes vomiting or diarrhea.

12 . The method of claim 1 , wherein the functioning of the digestive system, immune system, endocrine system or cardiovascular system is enhanced.

13 . The method of claim 12 , wherein the cardiovascular system is enhanced via dissolving of artherosclerotic plaques, improving of blood circulation, lowering of blood pressure, and/or fibrinolysis.

14 . The method of claim 1 , symptoms of Irritable Bowel Syndrome, Type 1 diabetes, Celiac disease, colorectal cancer, neurodevelopmental diseases or neurodegenerative diseases are ameliorated.

15 . The method of claim 1 , wherein digestive conditions and/or digestive symptoms selected from dehydration, nausea, vomiting, diarrhea, constipation, gas, bloating, food sensitivities, heartburn, acid-reflux, GERD, indigestion, and abdominal cramps/pain are ameliorated.

16 . The method of claim 1 , wherein extra-intestinal symptoms associated with a health condition, wherein the symptoms are selected from headaches, dizziness, fatigue, backaches, insomnia, eating disorders, nutrient deficiencies, depression, anxiety, fertility issues, joint or muscle pain, brain fog, genital yeast infections, bacterial vaginosis, and bladder or urinary tract infections are ameliorated.

17 . An ingestible composition comprising water, a biosurfactant,

an electrolyte,

a beneficial microorganism, and

one or more additives selected from nutrients, vitamins, minerals, herbal extracts, proteins, amino acids, antioxidants, and health supplements.

18 . (canceled)

19 . The composition of claim 17 , comprising a biosurfactant selected from glycolipids, lipopeptides and/or phospholipids.

20 - 21 . (canceled)

22 . The composition of claim 17 , wherein the one or more beneficial microorganisms are Bacillus spp., Bacteroides spp., Bifidobacterium spp., and/or Lactobacillus spp.

23 . The composition of claim 22 , wherein the microorganism is selected from Bacillus subtilis natto, Bacillus amyloliquefaciens or Bacillus coagulans.

24 . The composition of claim 17 , comprising one or more additives selected from nattokinase, CoQ10 and cannabidiol.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Nov 18, 2024
From: U.S. BANK TRUST COMPANY
To: LOCUS SOLUTIONS, LLC; LOCUS MANAGEMENT GP, INC.; LOCUS MANAGEMENT, LLC; LOCUS IP COMPANY, LLC; LOCUS OIL HOLDING, LLC,; LOCUS BIO-ENERGY SOLUTIONS, LLC; LOCUS OIL IP COMPANY, LLC; LOCUS AGRICULTURE HOLDING, LLC; LOCUS AGRICULTURAL SOLUTIONS, LLC; LOCUS AGRICULTURE IP COMPANY, LLC,; LOCUS SOLUTIONS IPCO, LLC; LOCUS SOLUTIONS IPHOLDCO, LLC; LOCUS CONSUMER BRANDS HOLDING, LLC; ARCTIVA WELLNESS, LLC
Reel/Frame 069386/0272 →
SECURITY INTEREST Recorded Nov 11, 2024
From: LOCUS SOLUTIONS IPCO, LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 069333/0911 →
RELEASE OF SECURITY INTEREST Recorded Oct 30, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: LOCUS SOLUTIONS IPCO, LLC
Reel/Frame 069273/0361 →
SECURITY INTEREST Recorded Dec 8, 2023
From: LOCUS SOLUTIONS IPCO, LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS THE COLLATERAL AGENT
Reel/Frame 065836/0868 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2023
From: LOCUS IP COMPANY, LLC
To: LOCUS SOLUTIONS IPCO, LLC
Reel/Frame 065615/0905 →
SECURITY INTEREST Recorded Dec 7, 2022
From: LOCUS SOLUTIONS, LLC; LOCUS MANAGEMENT GP, INC.; LOCUS MANAGEMENT, LLC; LOCUS IP COMPANY, LLC; LOCUS OIL HOLDING, LLC; LOCUS BIO-ENERGY SOLUTIONS, LLC; LOCUS OIL IP COMPANY, LLC; LOCUS AGRICULTURE HOLDING, LLC; LOCUS AGRICULTURAL SOLUTIONS, LLC; LOCUS AGRICULTURE IP COMPANY, LLC; LOCUS SOLUTIONS IPCO, LLC; LOCUS SOLUTIONS IPHOLDCO, LLC; LOCUS CONSUMER BRANDS HOLDING, LLC; ARCTIVA WELLNESS, LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 062079/0829 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2022
From: LOCUS IP COMPANY, LLC
To: LOCUS SOLUTIONS IPCO, LLC
Reel/Frame 062054/0132 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2022
From: FARMER, SEAN; ALIBEK, KEN
To: LOCUS IP COMPANY, LLC
Reel/Frame 059146/0088 →